1.Research progress of neuromelanin and the pathogenesis of Parkinson′s disease
Lu WANG ; Yayun YAN ; Liyao ZHANG ; Xiufeng LIU ; Yan LIU ; Ruirui LUO ; Ying CHANG
Chinese Journal of Neurology 2020;53(11):954-958
Parkinson′s disease (PD) is a common neurodegenerative disease. Its main pathological feature is the progressive loss of substantia nigra and other catecholaminergic neurons containing neuromelanin (NM). Therefore, NM may be closely related to the pathogenesis of PD. The content of NM can be detected by NM magnetic sensitive sequence imaging, and then it can be applied to the study of the neuropathological mechanism of NM and PD. This paper focuses on the physiological significance of NM, its role in the pathogenesis of PD and the prospect of NM as a biomarker to assist diagnosis and disease monitoring of PD.
2.Disease burden of influenza in children and current status of vaccine usage in China
Muli ZHANG ; Zhibin PENG ; Jiandong ZHENG ; Yayun TAN ; Xuan WANG ; Ying QIN ; Luzhao FENG
Chinese Journal of Applied Clinical Pediatrics 2019;34(2):91-97
The annual deaths associated with influenza is estimated to be between 290 000 and 650 000,which caused substantial burden to the society.Children have the highest incidence of influenza among all age groups,which can cause overloaded medical visits and a significant increase of hospitalization risk.The severe economic burden includes not only the direct medical costs due to outpatients and hospitalization,but also the indirect burden of school absence of children and work absence of their family members.Annual vaccination is the best measure to prevent influenza,however,influenza vaccination coverage among children in China is very low,and influenza vaccination has not yet been included in the National Immunization Program.Now,the disease burden of influenza and the vaccine usage in children in China were reviewed,and in order to provide evidence for influenza control and prevention.
3.Prognosis of fetuses with cystichygroma and nuchal translucency/nuchal fold thickening on prenatal echography.
Yayun WANG ; Yuan CHEN ; Mengmeng YANG ; Fangfang XI ; Qitao ZHAN ; Ying JIANG ; Baihui ZHAO ; Qiong LUO
Journal of Zhejiang University. Medical sciences 2019;48(4):434-438
OBJECTIVE:
To analyze the prognosis of fetuses with cystic hygroma (CH) or nuchal translucency (NT) or nuchal fold (NF) thickening detected by prenatal echography.
METHODS:
From January 2014 to December 2015, 124 fetuses with CH and NT/NF thickening on prenatal echography were enrolled from Women's Hospital of Zhejiang University School of Medicine. The basic clinical information, ultrasonic results, pregnancy outcomes and newborn follow-ups were analyzed. The cases were grouped by prognosis and the factors affecting prognosis were analyzed with logistic regression.
RESULTS:
There were 85 cases of labor induction including one stillbirth and 39 cases delivered. Except one infant who died after birth, all live births survived with good prognosis. Univariate analysis showed that the gestational age at diagnosis of poor prognosis group was earlier than that of good prognosis group (<0.01); and the former group also had higher hydrops fetalis rate and additional structural anomalies rate (all <0.01). Multivariate regression analysis showed that hydrops fetalis (=90.105, <0.05) and additional structural anomalies (=61.854, <0.05) were risk factors of poor prognosis in fetuses with CH and NT/NF thickening.
CONCLUSIONS
Fetuses with diagnosed CH or NT/NF thickening on prenatal ultrasonography are likely to be associated with chromosomal abnormality. Early gestational weeks, hydrops fetalis and additional structural anomalies may indicate poor prognosis.
Female
;
Fetus
;
Humans
;
Hydrops Fetalis
;
etiology
;
Infant, Newborn
;
Lymphangioma, Cystic
;
complications
;
diagnosis
;
Nuchal Translucency Measurement
;
Pregnancy
;
Pregnancy Outcome
;
Prognosis
;
Ultrasonography, Prenatal
4. Research progress of non-motor and extracerebellar symptoms in spinocerebellar ataxia type 2
Yuanyuan LI ; Ying CHANG ; Xiufeng LIU ; Liyao ZHANG ; Lu WANG ; Yayun YAN
Chinese Journal of Neurology 2019;52(11):961-967
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant degenerative disease. The main clinical manifestation of SCA2 is progressive cerebellar syndrome, but a wide range of extracerebellar and non-motor symptoms can be observed clinically. The non-motor symptoms and extra-cerebellar signs in SCA2 patients are reviewed to provide a better understanding in cognition, diagnosis and treatment of the disease.
5. Evaluation of the application of moving epidemic method on making influenza epidemic thresholds in the 7 climate zones in China
Yayun TAN ; Lingjia ZENG ; Ying QIN ; Jiandong ZHENG ; Zhongjie LI ; Dayan WANG ; Tao CHEN ; Luzhao FENG ; Zhibin PENG
Chinese Journal of Preventive Medicine 2019;53(10):1007-1011
Objective:
We planned to evaluate the effectiveness of moving epidemic method (MEM) in calculating influenza epidemic threshold of 7 climatic zones in China mainland.
Methods:
The positive rate of influenza virus was obtained from the National Influenza Surveillance Network System from 2010/2011 to 2017/2018. We divided the 31 provinces into 7 climatic zones according to previous literatures and applied MEM to calculate the influenza epidemic threshold of 2018/2019 influenza season for these climatic zones. Sensitivity, specificity, positive predictive value and negative predictive value were calculated to evaluate the effectiveness of MEM.
Results:
Pre-epidemic threshold (the positive rate of influenza virus) varied from 9.66% (temperate zone) to 16.36% (subtropical zone) for 2018/2019 influenza season. The gap between pre-epidemic and post-epidemic thresholds was less than 5% except for plateau zone. The sensitivity was 86.16% (95
6.Role of Siglecs and their ligands in the establishment of immune tolerance at maternal-fetal interface
Yayun ZHENG ; Ying FENG ; Dongmei SU ; Xue ZHOU ; Fang MA
Chinese Journal of Microbiology and Immunology 2019;39(4):316-320
Embryo is regarded as a semi-allograft for carrying paternal genetic information. It can escape the attack from maternal immune system and successfully implant into the uterus, which mainly relies on the establishment of immune tolerance at the maternal-fetal interface. The maternal-fetal interface is the basis for the connection and material exchange between the mother and fetus. The mechanisms of immune re-sponses at this interface are the key to the maintenance of normal pregnancy. Immunomodulatory molecules expressed at the maternal-fetal interface are vital for immune tolerance. Studies have shown that sialicacid-binding immunoglobulin-like lectins (Siglecs) are abundantly expressed at the maternal-fetal interface and play an important role in immune regulation. Siglecs are important members of the typeⅠimmunoglobulin-like superfamily. By binding with the sialic acid residues on the side chains of glycoproteins or glycolipids, Siglecs involve in immune regulation, the activation and proliferation of immune cells and immune cell-medi-ated physiological and pathological processes. Present research on the expression of Siglecs in the maternal-fetal interface is mainly focused on Siglec-6 and Siglec-10, while other Siglecs are less studied. Siglecs, such as Siglec-6 and Siglec-10, might involve in the regulation of immune tolerance at the maternal-fetal in-terface through binding to different ligands. This article briefly reviewed the expression of Siglecs and their ligands at the maternal-fetal interface and their roles in immune tolerance.
7.Evaluation of the application of moving epidemic method on making influenza epidemic thresholds in the 7 climate zones in China
Yayun TAN ; Lingjia ZENG ; Ying QIN ; Jiandong ZHENG ; Zhongjie LI ; Dayan WANG ; Tao CHEN ; Luzhao FENG ; Zhibin PENG
Chinese Journal of Preventive Medicine 2019;53(10):1007-1011
Objective We planned to evaluate the effectiveness of moving epidemic method (MEM) in calculating influenza epidemic threshold of 7 climatic zones in China mainland. Methods The positive rate of influenza virus was obtained from the National Influenza Surveillance Network System from 2010/2011 to 2017/2018. We divided the 31 provinces into 7 climatic zones according to previous literatures and applied MEM to calculate the influenza epidemic threshold of 2018/2019 influenza season for these climatic zones. Sensitivity, specificity, positive predictive value and negative predictive value were calculated to evaluate the effectiveness of MEM. Results Pre?epidemic threshold (the positive rate of influenza virus) varied from 9.66% (temperate zone) to 16.36% (subtropical zone) for 2018/2019 influenza season. The gap between pre?epidemic and post?epidemic thresholds was less than 5% except for plateau zone. The sensitivity was 86.16% (95CI: 66.81% - 98.23%), the specificity was 94.92% (95CI:91.13%-98.41%), the positive predictive value was 89.87% (95% CI : 84.39%-94.38%), the negative predictive value was 92.96% (95%CI: 84.46%-99.17%). Conclusion Overall, moving epidemic Method performs well in calculating influenza epidemic threshold in China, much better than the previous study.
8.Evaluation of the application of moving epidemic method on making influenza epidemic thresholds in the 7 climate zones in China
Yayun TAN ; Lingjia ZENG ; Ying QIN ; Jiandong ZHENG ; Zhongjie LI ; Dayan WANG ; Tao CHEN ; Luzhao FENG ; Zhibin PENG
Chinese Journal of Preventive Medicine 2019;53(10):1007-1011
Objective We planned to evaluate the effectiveness of moving epidemic method (MEM) in calculating influenza epidemic threshold of 7 climatic zones in China mainland. Methods The positive rate of influenza virus was obtained from the National Influenza Surveillance Network System from 2010/2011 to 2017/2018. We divided the 31 provinces into 7 climatic zones according to previous literatures and applied MEM to calculate the influenza epidemic threshold of 2018/2019 influenza season for these climatic zones. Sensitivity, specificity, positive predictive value and negative predictive value were calculated to evaluate the effectiveness of MEM. Results Pre?epidemic threshold (the positive rate of influenza virus) varied from 9.66% (temperate zone) to 16.36% (subtropical zone) for 2018/2019 influenza season. The gap between pre?epidemic and post?epidemic thresholds was less than 5% except for plateau zone. The sensitivity was 86.16% (95CI: 66.81% - 98.23%), the specificity was 94.92% (95CI:91.13%-98.41%), the positive predictive value was 89.87% (95% CI : 84.39%-94.38%), the negative predictive value was 92.96% (95%CI: 84.46%-99.17%). Conclusion Overall, moving epidemic Method performs well in calculating influenza epidemic threshold in China, much better than the previous study.
9. Technical guidelines for seasonal influenza vaccination in China (2018-2019)
Luzhao FENG ; Zhibin PENG ; Dayan WANG ; Peng YANG ; Juan YANG ; Yanyang ZHANG ; Jian CHEN ; Shiqiang JIANG ; Lili XU ; Min KANG ; Tao CHEN ; Yaming ZHENG ; Jiandong ZHENG ; Ying QIN ; Mengjiao ZHAO ; Yayun TAN ; Zhongjie LI ; Zijian FENG
Chinese Journal of Preventive Medicine 2018;52(11):1101-1114
Seasonal influenza vaccination is the most effective way to prevent influenza virus infection and complications from infection. Currently, China has licensed trivalent inactivated influenza vaccine (IIV3) and quadrivalent inactivated influenza vaccine (IIV4), including split-virus influenza vaccine and subunit vaccine. Except for a few major cities, influenza vaccine is a category Ⅱ vaccine, which means influenza vaccination is voluntary, and recipients must pay for it. To strengthen the technical guidance for prevention and control of influenza and operational research on influenza vaccination in China, the National Immunization Advisory Committee (NIAC) Influenza Vaccine Technical Working Group (TWG), updated the 2014 technical guidelines and compiled the "Technical guidelines for seasonal influenza vaccination in China (2018-2019)" . The main updates in this version include: epidemiology, disease burden, types of influenza vaccines, northern hemisphere influenza vaccination composition for the 2018-2019 season, IIV3 and IIV4 immune response, durability of immunity, immunogenicity, vaccine efficacy, effectiveness, safety, cost-effectiveness and cost-benefit. The influenza vaccine TWG provided the recommendations for influenza vaccination for the 2018-2019 influenza season based on existing scientific evidence. The recommendations described in this report include the following: Points of Vaccination clinics (PoVs) should provide influenza vaccination to all persons aged 6 months and above who are willing to be vaccinated and do not have contraindications. No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one licensed, recommended, and appropriate product is available. To decrease the risk of severe infections and complications due to influenza virus infection among high risk groups, the recommendations prioritize seasonal influenza vaccination for children aged 6-59 months, adults ≥60 years of age, persons with specific chronic diseases, healthcare workers, the family members and caregivers of infants <6 months of age, and pregnant women or women who plan to become pregnant during the influenza season. Children aged 6 months through 8 years require 2 doses of influenza vaccine administered a minimum of 4 weeks apart during their first season of vaccination for optimal protection. If they were vaccinated in 2017-2018 influenza season or a prior season, 1 dose is recommended. People more than 8 years old require 1 dose of influenza vaccine. It is recommended that people receive their influenza vaccination by the end of October. Influenza vaccination should be offered as soon as the vaccination is available. For the people unable to be vaccinated before the end of October, influenza vaccination will continue to be offered for the whole season. Influenza vaccine is also recommended for use in pregnant women during any trimester. These guidelines are intended for use by staff members of the Centers for Disease Control and Prevention at all levels who work on influenza control and prevention, PoVs staff members, healthcare workers from the departments of pediatrics, internal medicine, and infectious diseases, and staff members of maternity and child care institutions at all levels.
10.Research progress of respiratory dysfunction in Parkinson's disease
Yanyan LI ; Yayun YAN ; Yuanyuan LI ; Xiufeng LIU ; Ying CHANG
Chinese Journal of Neurology 2018;51(8):652-656
Parkinson's disease (PD) is a common disabling and neurodegenerative disease.As the disease progresses,the patient's respiratory system will be affected.PD leads to obstructive and restrictive airway diseases,and PD medications may produce pulmonary side effects,such as pleuropulmonary fibrosis related to dopamine agonists.Finally,motor fluctuations in advanced PD may trigger respiratory symptoms.Abnormal central control of ventilation,obstructive sleep apnea,emotional disorders will influence respiratory system.Recognizing these pulmonary complications will assist the clinician in appropriately managing the disease and potentially reducing the impact of the abnormal respiratory system on overall PD patient health.

Result Analysis
Print
Save
E-mail